These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 36967808)

  • 1. Effects of intestinal flora on polycystic ovary syndrome.
    Liu J; Liu Y; Li X
    Front Endocrinol (Lausanne); 2023; 14():1151723. PubMed ID: 36967808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome.
    Ding H; Zhang J; Zhang F; Zhang S; Chen X; Liang W; Xie Q
    Front Endocrinol (Lausanne); 2021; 12():741764. PubMed ID: 34745009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome.
    Wang J; Wu D; Guo H; Li M
    Life Sci; 2019 Nov; 236():116940. PubMed ID: 31604107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: Oxidative stress in polycystic ovary syndrome.
    Rudnicka E; Duszewska AM; Kucharski M; Tyczyński P; Smolarczyk R
    Reproduction; 2022 Dec; 164(6):F145-F154. PubMed ID: 36279177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic Ovary Syndrome: Insights from Preclinical Research.
    Reckelhoff JF; Shawky NM; Romero DG; Yanes Cardozo LL
    Kidney360; 2022 Aug; 3(8):1449-1457. PubMed ID: 36176644
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
    Siddiqui S; Mateen S; Ahmad R; Moin S
    J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis.
    Zhu Y; Li Y; Liu M; Hu X; Zhu H
    Front Endocrinol (Lausanne); 2020; 11():575. PubMed ID: 32973686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.
    Popovska-Dimova Z; Krstevska B
    Prilozi; 2006 Jul; 27(1):87-95. PubMed ID: 16985482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune regulation in polycystic ovary syndrome.
    Luan YY; Zhang L; Peng YQ; Li YY; Liu RX; Yin CH
    Clin Chim Acta; 2022 Jun; 531():265-272. PubMed ID: 35447143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin and hyperandrogenism in women with polycystic ovary syndrome.
    Baptiste CG; Battista MC; Trottier A; Baillargeon JP
    J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):42-52. PubMed ID: 20036327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance.
    Herman R; Sikonja J; Jensterle M; Janez A; Dolzan V
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities and challenges: interleukin-22 comprehensively regulates polycystic ovary syndrome from metabolic and immune aspects.
    Geng Y; Liu Z; Hu R; Ma W; Wu X; Dong H; Song K; Xu X; Huang Y; Li F; Song Y; Zhang M
    J Ovarian Res; 2023 Jul; 16(1):149. PubMed ID: 37525285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.
    Huang R; Zheng J; Li S; Tao T; Ma J; Liu W
    Acta Obstet Gynecol Scand; 2015 May; 94(5):494-500. PubMed ID: 25711494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormone-binding globulin and polycystic ovary syndrome.
    Zhu JL; Chen Z; Feng WJ; Long SL; Mo ZC
    Clin Chim Acta; 2019 Dec; 499():142-148. PubMed ID: 31525346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.